Parameters affecting tumour control and toxicity in oesophageal cancer: a multi-dimensional outcome analysis

Doctoral thesis English OPEN
Carrington, Dewi Rhys (2016)
  • Subject: RC0254

The work contained within this thesis explores the relationship between clinical and technological parameters of radiotherapy treatment planning and patient outcome in patients who were treated for cancer of the oesophagus as part of the SCOPE 1 clinical trial. However the methods and concepts of the work could also have applications at other tumour sites.\ud By developing ideas from previous studies, a novel method of applying a conformity index found a significant relationship between the quality of a radiotherapy plan and patient outcome in terms of overall survival. Furthermore it was found that the plan quality could be improved by utilising a relatively new method of dose delivery. This dose delivery method also allowed the improving of tumour control via dose escalation to be explored via radiobiological modelling. The results of this work showed that although the probability of controlling the tumour is increased, there is also a significantly higher risk of increased gastric toxicity for patients with lower oesophageal tumours. Interfraction gastric movement was also investigated with the end result being a recommendation for stomach movement and toxicity to be minimised by using a pre-treatment protocol. This is being taken forward in a nationwide multicentre clinical trial. Finally a texture analysis software package was used to investigate whether there was relationship between the image heterogeneity parameters of computed tomography images and patient outcome. This work could potentially aid the decision making process of radiotherapy treatment, allowing a more informed judgement to be made on the most beneficial treatment for the patient.
  • References (8)

    29. Hurt G, Nixon L, Griffiths G, Al-Mokhtar R, Gollins S, Staffurth J, et al. SCOPE1: a randomised phase II/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesphagus. BMC Cancer. 2011;11:466-78.

    30. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. New England J Medicine. 2006;354(6):567-78.

    31. El Naqa I, Suneja G, Lindsay PE, Hope AJ, Alaly JR, Vicic M, et al. Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships. Phys Med Biol. 2006;51:5719-35.

    32. Ten Haken RK, Martel MK, Lawrence TS. Use of dose-volume-response factors in conformal high-dose therapy studies. In: A.R. Hounsell, J.M. Wilkinson, P.C. Williams, editors. XIth International Conference on the Use of Computers in Radiaiton Therapy: Handley Printers, Ltd, Manchetser, UK; 1994. p. 22-3.

    33. El Naqa I, Bradley J, Blanco AI, Lindsay PE, Vicic M, Hope A, et al. Multivariable modelling of radiotherapy outcomes, including dose-volume and clinical factors. Int J Radiation Oncology Biol Phys. 2006;64(4):1275-86.

    34. Elshaikh M, Ljungman M, Ten Haken R, Lichter AS. Advances in Radiation Oncology. Annual Review of Medicine. 2006;57(1):19-31.

    35. Griffiths EA, Brummell Z, Gorthi G, Pritchard SA, Welch IM. Tumour length as a prognostic factor in esophageal malignancy: Univariate and multivariate survival analyses. J Surg Oncol. 2006;93:258-67.

    36. Wang BY, Goan YG, Hsu PK, Hsu WH, Wu YC. Tumour length as a prognostic factor in esophageal squamous cell carcinoma. Ann Thorac Surg. 2011;91:887-94.

  • Related Research Results (1)
  • Metrics
    0
    views in OpenAIRE
    0
    views in local repository
    66
    downloads in local repository

    The information is available from the following content providers:

    From Number Of Views Number Of Downloads
    Online Research @ Cardiff - IRUS-UK 0 66
Share - Bookmark